| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.005 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.17 | 0.005 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.08 | 0.007 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.009 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |